SAM
ATRS

Sawgrass Asset Management’s Antares Pharma, Inc. ATRS Stock Holding History

Sawgrass Asset Management’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-48,255
Closed -$176K – 329
2021
Q3 		$176K Sell
48,255
-3,300
-6% -$13.3K 0.02% 161
2021
Q2 		$225K Hold
51,555
– – 0.02% 158
2021
Q1 		$212K Buy
+51,555
New +$223K 0.02% 156

Other funds holding ATRS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
FWSM
First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

Sawgrass Asset Management's ATRS Position: Q4 2021 in Review

Sawgrass Asset Management sold out of Antares Pharma, Inc. (ATRS) in Q4 2021, closing a stake of 48,255 shares — an estimated $176K sold.

Sawgrass Asset Management first reported a position in ATRS in Q1 2021 and held it in 3 quarters. The position peaked at $225K in Q2 2021. 162 funds tracked by Wall St. Rank hold ATRS as of Q4 2021.

  • Sawgrass Asset Management reported no remaining Antares Pharma, Inc. position as of Q4 2021 after selling out during the quarter.
  • Sawgrass Asset Management sold 48,255 Antares Pharma, Inc. shares in Q4 2021, an estimated $176K.
  • Sawgrass Asset Management first reported a position in Antares Pharma, Inc. in Q1 2021 and held it in 3 quarters.
  • Sawgrass Asset Management's Antares Pharma, Inc. position peaked at $225K in Q2 2021.
  • 162 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q4 2021.

Based on Sawgrass Asset Management's 13F filing for Q4 2021, filed 3 Feb 2022.